SFRP5 and fatty liver disease: Interestingly, some genes that have been described to suppress the high body fat phenotype, hepatic steatosis, and potentially also myosteatosis are strongly downregulated in tumors because they are putative tumor-suppressor genes, such as SFRP1, SFRP5, and DKK3 [42].